← Mechanisms of action
AGT
SINGLE PROTEINHomo sapiens
Preferred name: Angiotensinogen ChEMBL ↗
Linked proteins
Drugs acting on this target (14)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| cilexetil | Antagonist | experimental | Small molecule | AGT antagonist |
| daa-i | Antagonist | experimental | Peptide | AGT antagonist |
| ion904 | Antisense inhibitor | experimental | Nucleic acid | AGT antisense inhibitor |
| sgb-3908 | Antisense inhibitor | experimental | Nucleic acid | AGT antisense inhibitor |
| cyt006-angqb | Immunity, active | experimental | Vaccine | AGT immunity, active |
| immuvac | Immunity, active | experimental | Vaccine | AGT immunity, active |
| aln-agt01 | Inhibitor | experimental | Nucleic acid | AGT inhibitor |
| besylsartan | Inhibitor | experimental | Small molecule | AGT inhibitor |
| hrs-9563 | Inhibitor | experimental | Small molecule | AGT inhibitor |
| o6-benzylguanine | Inhibitor | experimental | Small molecule | AGT inhibitor |
| syh2062 | Inhibitor | experimental | Small molecule | AGT inhibitor |
| aclerastide | Supplementation | experimental | Peptide | AGT supplementation |
| angiotensin 1-7 | Supplementation | experimental | Peptide | AGT supplementation |
| gsk2586881 | Supplementation | experimental | Recombinant protein | AGT supplementation |